2-Methoxypyrimidine-5-boronic acid → HCID 90035980, compound

HRID 925759Notes

Reaction equation

HRID 925759 reaction equation
Br[C:2]1[C:10]2[N:9]3[CH2:11][CH2:12][NH:13][C:14](=[O:15])[C:8]3=[C:7]([CH3:16])[C:6]=2[CH:5]=[C:4]([Cl:17])[CH:3]=1.[CH3:18][O:19][C:20]1[N:25]=[CH:24][C:23](B(O)O)=[CH:22][N:21]=1>>[Cl:17][C:4]1[CH:3]=[C:2]([C:23]2[CH:22]=[N:21][C:20]([O:19][CH3:18])=[N:25][CH:24]=2)[C:10]2[N:9]3[CH2:11][CH2:12][NH:13][C:14](=[O:15])[C:8]3=[C:7]([CH3:16])[C:6]=2[CH:5]=1

Participants

3

Procedure

The title compound, white solid (68 mg, 79%), MS (ISP) m/z=343.5 [(M+H)+], mp 270.5° C., was prepared in accordance with the general method of example 1 from 6-bromo-8-chloro-10-methyl-3,4-dihydro-2H-pyrazino[1,2-a]indol-1-one (intermediate 12) (78.4 mg, 0.25 mmol) and commercially available 2-methoxypyrimidin-5-ylboronic acid (50.0 mg, 0.325 mmol).

Sources & evidence

ORD record
ord-6f390fa3b63e49f3a716bc6d26d32c6e
Source dataset
uspto-grants-2016_03
Patent number
US09284321B2

Reaction notes

Loading…